chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red swelling on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (red swelling on the left arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, C31L2A and C31L2A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy and Gastro-intestinal disorder NOS. Concomitant products included LUBIPROSTONE and BUPROPION for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, the patient experienced VACCINATION SITE SWELLING (red swelling on the left arm). At the time of the report, VACCINATION SITE SWELLING (red swelling on the left arm) had not resolved.            Other concomitant medications included Allergy medication, name was not specified and patient was also taking digestive medication. For treatment Patient put ice to reduce the swelling The swelling is still ongoing. Patient had taken her booster shot around 4 PM on Fri 19th Nov. The patient stated that She had no reaction after the first and second dose.
CDC Reports:2 yo child developed fever 104 & 2 convulsions following DTP/OPV/HIB immun., hospitalized
This spontaneous case was initially received on 09-Oct-2015. The case report was received from a Health Professional and concerns a patient with unknown age and gender. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refers to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication protection against seasonal influenza virus on 08-Oct-2015- 08-Oct-2015, Batch no: T57505, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 08-Oct-2015, the patient experienced received an IM (intramuscular) dose of AFLURIA that had expired on 30-May-2015 (non serious, outcome: Unknown). Action taken: Discontinued. Event treatment: not provided. Rechallenge/ Dechallenge information: not applicable. For relevant test results see appropriate report section. Please add other relevant test results manually as appropriate.
This spontaneous report as received from a physician via a company representative refers to a 67 years old female patient. The patient's medical history and concomitant medications were not reported. Her concurrent conditions included Diabetes. None drug reactions/allergies reported. On an unknown date (reported as at the age of 65 years old), the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route of administration, lot # and expiration date were not reported). On an unknown date (reported as at the age of 67 years old), the patient was diagnosed with Pneumonia. The patient also developed an active case of shingles two days after developing Pneumonia. On an unknown date, the patient had a chest x-ray that confirmed the pneumonia. The patient was prescribed an unspecified antiviral treatment for the shingles and an unspecified antibiotic and prednisone (manufacturer unknown). The patient's lungs cleared five days after using the antibiotic and the prednisone (manufacturer unknown). The outcome of pneumonia was reported as recovered on an unknown date. The outcome of shingles was unknown. The relatedness between the adverse events and the vaccination with PNEUMOVAX23 was not reported. Additional information has been requested.
The day she got the shot she woke up with excruciating pain in the back of her neck. now has a headache and pain is between shoulder blades and down back of neck. received vaccine on 2/20/20. has been taking Tylenol every 4 hours and is not helping. Symptoms were so bad when they started woke her up, she hurts all the time. Denies any numbness or tingling. Wants to note she had cancer, last January had a lumpectomy and radiation treatments.
pt recvd Engerix-B inadvertently-nurse attempted to give a PPD test;w/in 48hrs p/vax pt exp induration & erythema inj site;
Dx: Pericarditis s/s: Dyspnea on exertion, edema, fever/chills unknown symptom onset date, patient poor historian.   diagnosed with pericardial effusion, suspect pericarditis. viral panel negative. etiology not defined  defined as acute on chronic dyspnea and acute CHF
Tested positive for COVID19 on 12-30-2020, Admitted to Hospital on 1/5/2021 with active COVID, Patient died 1/29/2021.
14 year old received vaccine. Mother of patient was contacted to discuss and cancel 2nd dose appointment. Mother stated that she brought this up to hospital staff who said that it was OK to give as long as she consented. Unknown which staff member said that. All staff are being educated on the age limit of 16 for Pfizer brand COVID vaccine.
1) AFTER THE FIRST SHOT, THE MIDDLE FINGER ON THE LEFT HAND, THE JOINT KEEPS POPING EVERY MORNING AFTER THE SECOND SHOT. THE RING THE MIDDLE AND INDEX FINGERS JOINTS ARE POPING. CAN NOT STRETCH FINGERS OUT WITHOUT HELP FROM RT HAND.   2) 2ND SHOT, PAIN AT THE INJECTION SITE, HEADACHE, CHILLS, TIREDNESS   3) AFTER THE 2ND SHOT, LUMPAND SWELLING UNDER ARMPIT AND LUMP AND SWELLING ON SHOULDER  4) ENTIRE LEFT SIDE OF BODY IS FEELING SOME KIND OF WEIRD SHARP PAIN  5) WEEK OF 2/22/2021, THERE IS A LUMP AND SWELLING ON MY RIGHT SIDE NOW TOO. THERE IS SOME PAIN BUT NOT AS BAD AS THE LEFT SIDE.   6) 3/3/2021, RASH ON LOWER BACK.   7) 3/4/2021, RASH ON LOWER BACK HAS SPREAD TO MY SIDES AND TO BOTHSIDES OF MY BREAST, SOME RASH ON MY NECK ALSO.   8) SINCE THE 2nd SHOT I HAVE ALSO HAD WARM FEELING, ANY TIME THE LEFT SIDE GETS IRRITATED.   9) WEEK OF 3/1/2021, NONE OF THE SYMPTOMS / ADVERSSE REACTIONS HAVE GONE AWAY
Initial report was received from a healthcare professional on 16 September 2013. This case involves a cluster of three unidentified patients who experienced adverse events following FLUZONE administration. Three unidentified patients received a dose of FLUZONE (Sanofi Pasteur; lot number, route, site and date of administration not reported) and an unspecified amount of time later experienced reactions of swelling, knot and cellulitis at the injection site. No additional information was provided. Outcome was unknown. Documents held by sender: None. Follow-up information received from a healthcare professional on 24 October 2013: The reporter stated that she did not have any patient information or vaccine details. She heard from Employee Health and thought patients were all employees.
Case number PHEH2011US04998 is an initial spontaneous report received from a nurse on 16 Sep 2011. This report refers to 4-month-old female patient. She was given only the MenA lyophilized conjugate component of MENVEO (batch number:A10047) that was reconstituted with a sterile diluent, intramuscularly on 08 Sep 2011. No adverse reaction had occurred following this drug administration error.
Presented after collapsing at home; bradycardic, hypothermic; + covid CXR: bilat pleural effusions and PNA, Intubated in ED; labs: CRP: 11.09; Tx: Maxipime, Rocephin, Decadron, heparin; Initially on epi gtt, weaned off by day 2; family decided on comfort care
Multiple extremely swollen lymph nodes around ear, jaw, and neck on right side of body. (Opposite of injection side) Appeared day after the shot and is still present 1 week afterwards.   Swollen painful bumps on right side of the forehead and eyebrow.
3rd vaxx (as booster) received Nov 2021. Injection site remains painful (feels like a bad bruise). Lymph nodes on left armpit were swollen for approximately 6 weeks after last vaxx and area remains tender 8 months later.
cough, SOB, diarrhea, nausea, vomiting, myalgias
The patient has almost immediate (2 minutes) redness and itching surrounding the site.  She developed a 3.5? red circular rash with its center at the injection site.  She did not develop any other symptoms. She was given Claritin with improvement in 30 minutes.  She was observed for 1.5 hours and released with no further symptoms. She will take daily Claritin for a week.  She has an allergic history (delayed hypersensitivity)
Information has been received from a health professional concerning a 9 year old male who was vaccinated with a dose of varicella virus vaccine live.  On 13-MAR-2006 the patient presented with a case of breakthrough chickenpox.  His lesions were very small and itchy.  Unspecified medical attention was sought.  At the time of the report the patient had not yet recovered.  There was no product quality complaint involved.  Additional information has been requested.
c/o right arm itching approximately 4 days after injection.  large, white, raised area (approximately 1/2 inch by 2 inches) surrounded by a red rash area.  Saw Physician 7/24/06 at 4pm.
This spontaneous report as received from a physician via a field representative regarding a currently 75 year old male patient. His past drug included PREVNAR 13 in 2017 (also reported about one year ago). His medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot and expiry date were unknown) 1 dose via an unknown route for pneumonia prevention. On an unspecified date after receiving the vaccine, the patient developed injection site swelling and shortness of breath. It was reported that, the patient sought medical attention by going to the emergency room on an unspecified date at an unknown hospital. However, the patient was not hospitalized and he was released from the emergency room on the same day. Treatment administered for the events was unknown. The patient did have a follow-up visit with the physician on 26-MAR-2018 (reported as this past Monday). The outcome of dyspnoea and injection site swelling were reported as recovered on an unknown date. The causality assessment was not provided by the reporter. No product quality complaint (PQC) was present.
Mucho dolor de cuerpo / lot of body pain; Mucho dolor de cabeza / bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Mucho dolor de cuerpo / lot of body pain) and HEADACHE (Mucho dolor de cabeza / bad headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included NAPROXEN SODIUM (ALEVE) and DICLOFENAC for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN (Mucho dolor de cuerpo / lot of body pain) and HEADACHE (Mucho dolor de cabeza / bad headache). At the time of the report, PAIN (Mucho dolor de cuerpo / lot of body pain) and HEADACHE (Mucho dolor de cabeza / bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient did not take any treatment medication.
Description: rash 10 days after SMPX, MEN, AVA vaccine. Believes due to SMPX vaccine. Symptom: Rash, diffuse start: 03/10/2003 Comment: 782.1 periodic flare ups persist 2008. Symptom: Cyst Start: 05/2007 End: 05/2007 Comment: 706.2 right scalp lesion. Symptom: Alopecia (Hair Loss) Start: 05/2007 Comment: 704.00 2 spots on scalp. Symptom: Lesions, Pustule Start: 03/10/2007 Comment: 709.8 weeping lesions have resolved w/prn flares. Approximately 7-8 days post SMPX vaccine (10 Mar 03) he noted small bumps to back of both hands and ears described as if having 'goose bumps'. Medical advised he may have scabies. Day 10 (two days later- 3/12/2003) while deploying Kuwait, the bumps on his right mid-thigh turned into an 'open lesion'. Medical placed him on a week of Prednisone and prescribed Atarax for the itching. By day 21 his rash was much better and resolving. However 2-3 days after completion of his Prednisone, his rash returned. He advised his SMPX site was crusty and weeping/oozing. Approximately 3-4 weeks post vaccination as transferred to Bagdad, he noted increased oozing to his fingers-hands, shoulders, hips, legs, arms and calves. He denied any problems with torso, back or his face. From June 2003-2007 he voiced 1 flare-up to his hands every 2-3 months. He knows of no triggers. In August 2004 while in Atlantic on vacation his hands began to weep while holding plastic. He denied any latex allergies but noted his mother has a latex allergy. Differential diagnoses: Lichen nitidus vs eczematous dermatitis vs spongiotic psoriasisiform
Information has been received from a registered nurse, for GARDASIL, a Pregnancy Registry product, concerning a 20 year old female with no known drug reactions or allergies and with no pertinent medical history who on 29-DEC-2011, presented to the family practice office symptomatic (specific symptoms unspecified0 and was vaccinated intramuscularly with a 0.5 ml dose of GARDASIL (Lot # 668670/0476AA). There was no concomitant medication. "The same day" on 29-DEC-2011 after GARDASIL vaccination, the patient had a pregnancy test that showed she was pregnant. The lab diagnostics studies performed also included chlamydia test, PAP, HIV screening. On 09-JAN-2012 the patient performed "full OB screen: CBC, rubella, RPR (syphilis screen), hepatitis B, hemoglobin A1C, blood type A positive" and no lab results provided. The nurse mentioned her gestation was 26 weeks and 1 day until now. Her LMP was on 13-NOV-2011. Expected date of delivery was on 19-AUG-2012. No further information was reported. Follow up information was received from a physician who reported that the 20 year old female patient with no medical history and no concurrent medical conditions and with no previous pregnancies, was vaccinated on 03-JAN-2013 (previously reported as 29-DEC-2011) with the first dose of GARDASIL (lot number 668670/0476AA). Estimated delivery date was reported as 19-AUG-2012. It was unknown that ultrasound, amniocentesis, MSAFP were done. On 22-AUG-2012, at 37 gestation week, the patient delivered normal full term female baby with no congenital anomaly. There were no other complications or abnormalities. Apgar score was 9, 9 for the baby. The baby's birth weight was 9lbs 8oz. There were no complications during pregnancy or during labor/delivery. Follow up information was received from a physician who reported that the patient had not medical history information and that she was vaccinated on 29-DEC-2011 (previously reported as 03-JAN-2012), with the first dose of GARDASIL. The patient used miconazole 2% vaginal cream QHS on 13-MAR-2012, for yeast infection. There were no complications during pregnancy; everything went fine and Estimated conception date was reported as 21-NOV-2011. Additional information is not expected.
Patient was believed to have fainted, falling forward and hitting head about 3-5 minutes after receiving first booster dose of Pfizer vaccine. Patient came to immediately, patient knew their name, the day and location. 911 was called immediately and EMS came and took patient to check vitals. Patient's vitals were all normal per guardian.
11/16/11 Flu & meningococcal vaccine in (L) deltoid - same arm. (L) deltoid 7 x 12 cm induration 11-18-11 erythema. No systemic signs or sxs. Localized - responded to BENADRYL.
Information has been received from a physician concerning an 80-year-old female who on 21-DEC-2006 was vaccinated with a dose of Zostavax. In early February 2007, the patient developed shingles in the chest region. It was noted that the shingles were in a staggered pattern. The patient has seen a dermatologist and has been prescribed Famvir for treatment. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Pt recv vax on 10/22/98; on 10/23/98 pt exp a mass at base of neck (right)
Light headedness, dizziness since vaccine series completed one year ago. Fainted 6/4/09.
Seen in ER 05/22/2012 at 22:36 with arched back & eyes appearing large. She had 3 very short spells lasting only seconds. Her temp was 101.6 at the highest. ER provider did not document seizure activity.
Pfizer vaccine.  Experienced nausea 3 hours after the vaccine. I took promethazine to relieve nausea. Went away 24 hours later. 3 days after vaccine, my lymph nodes on my neck became swollen. I am swollen after my surgery. but was not swollen in my neck I do receive 2 lymphatic drainage massages per week to try to get rid of it in other lymph node areas. Bad headache lasted only 5 hours after vaccine. Tenderness at vaccine site last 2 days. I also have body aches and sleepiness still (4 days later)
Pt has fever-mild (mom can't find thermometer), fussy, irritable; c/o leg hurting; no reddness, swelling or discoloration; Is distracted by play; recommend warm compresses, APAP, see MD if not better tomorrow will ck on Mon;
Shortness of breath, metallic taste in my mouth. Later developed prominent lymph nodes in lt axilla and neck which are still present. Had fever & body aches for 1 wk following each dose. Arthritis symptoms much more severe since vaccine, especially in rt hand which was virtually asymptomatic before vaccine.
Left thigh red, hot and swollen. Also complained of itching. Referred to doctor.
Information has been received from a nurse concerning a female who on 21-MAY-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 656923/0451U). On 29-MAY-2007 the patient received a second dose of varicella virus vaccine live (Oka/Merck) and experienced an injection site rash that measured 2" x 3" x 3" in diameter which was red, hot to the touch and swollen. Subsequently, the patient recovered from the injection site rash 2 days later after treatment with an antihistamine (therapy unspecified) and cold compresses. This is one of several reports received from the same source. Additional information is expected.
The 11 year old F presents with mom for reactions following recent vaccinations. On 2/24/2017 she received routine school required vaccinations (for 4th grade). She received Men vaccine (NOV lot#M15164) to right deltoid and BOOSTRIX (Lot #E7GM7) to left deltoid. Band-aids were applied. The next day she noted some redness under the left arm Band-Aid that continued to progress to current warm red, swollen area. They saw their HCP who referred to provider for further evaluation of this site reaction. Exam: General appearance was normal. Mobile. Texture was normal. Turgor was normal. Color and pigmentation were normal. Moisture was normal. Temperature was normal. Injection Site: Assessment on the right arm showed abnormalities Child had multiple single red papules in shape of Band-Aid to right deltoid over where MEN vaccine given 2.5x5 cm size. Otherwise skin normal, no axillary lymphadenopathy, weakness or limitations to in right arm/shoulder ROM. Assessment on the left arm showed abnormalities Child with total of 10x5cm trapezoid shaped slightly warm, red shaped area surrounding and just under Tdap vaccine site. Within this site was a 2.5x5 cm bandaid shape impression to top portion of this region that had multiple single red papules. Not itchy. There was 1 mobile axillary lymph node and no restriction in ROM to left arm/shoulder and no Paraesthesia, no weakness. Rash and oth nonspec skin eruption.
This spontaneous report as received from an office manager refers to a 6 month old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were unknown. On an unknown date the patient was vaccinated with a dose of VAQTA 25/0.5 (units unspecified) (dosing regimen and frequency unknown) (lot number and expiry date unknown) intramuscularly instead of a dose of influenza virus vaccine (unspecified)(manufacturer unknown) (dosing regimen and frequency unknown) (lot number and expiry date unknown) for prophylaxis (wrong drug administered). No adverse events were reported. There was no product quality compliant reported.
Swollen glands in neck; Headache; This is a spontaneous report from a contactable Consumer. This 75-year-old Female consumer (patient) reported that.  A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as (At the age of 75-years) dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced swollen glands in neck, and headache on an unspecified date. Consumer stated, she just wanted to check on some reactions she had his shot, second shot yesterday at about 1 o'clock and she was 75 years old. she had some swollen glands in his neck and some headache. Is that normal. Product details and further details could not be probed as consumer was unwilling to share further information. Hence further probing could not be done and limited information available over the call. The outcome of events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Reports HA and neck stiffness that initially occurred after receiving 2nd dose x7 days ago. Usually felt at night over the right side of her head. Last night spread to left side. Has ear fullness, nec stiffness/tenderness, and intermittent left hand numbness/tingling.
Pain at injection site, sore arm.  Especially not able after second injection (soreness was much worse) but stated no numbness from the injection as would be very concerned if this occurred.; Pain at injection site, sore arm.  Especially not able after second injection (soreness was much worse) but stated no numbness from the injection as would be very concerned if this occurred.; This is a spontaneous report from a contactable consumer. A 23-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number /expiration date: not provided), via an unspecified route of administration, on 05Jan2021 as a single dose for COVID-19 IMMUNIZATION. The patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number /expiration date: not provided), via an unspecified route of administration, on 26Jan2021 as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient experienced pain at injection site, sore arm with the first dose. On 26Jan2021, the patient experienced pain at injection site, sore arm with the second dose. The patient reported that it was especially notable after second injection (soreness was much worse) but stated no numbness from the injection. The patient believed the individual who administered the second dose may have administered too quickly causing the additional soreness. The events did not require hospitalization. The patient did not receive treatment for the events. The outcome of the events pain at injection site, sore arm was recovering. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Patient was vaccinated w/ INFANRIX DTaP in the left thigh on 7/21/14, came in 2 days later w/ redness, swelling, hot to touch local reaction at site of vaccine. She was treated w/ cephalexin 250mg/5mL 1 tsp tid x 10 days along w/ BENADRYL.
Within 15 minutes after shot, she had runny nose, itchy legs and cough.  Approximately 30 minutes later, she had hives, involving legs, arms and neck.  She later developed swollen eyelids.